Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Impaired natural killer cell phenotype and function in idiopathic and heritable pulmonary arterial hypertension.

Ormiston ML, Chang C, Long LL, Soon E, Jones D, Machado R, Treacy C, Toshner MR, Campbell K, Riding A, Southwood M, Pepke-Zaba J, Exley A, Trembath RC, Colucci F, Wills M, Trowsdale J, Morrell NW.

Circulation. 2012 Aug 28;126(9):1099-109. doi: 10.1161/CIRCULATIONAHA.112.110619. Epub 2012 Jul 25.

PMID:
22832786
2.

Selective reduction of natural killer cells and T cells expressing inhibitory receptors for MHC class I in the livers of patients with hepatic malignancy.

Norris S, Doherty DG, Curry M, McEntee G, Traynor O, Hegarty JE, O'Farrelly C.

Cancer Immunol Immunother. 2003 Jan;52(1):53-8. Epub 2002 Dec 10.

PMID:
12536240
3.

Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B.

Tjwa ET, van Oord GW, Hegmans JP, Janssen HL, Woltman AM.

J Hepatol. 2011 Feb;54(2):209-18. doi: 10.1016/j.jhep.2010.07.009. Epub 2010 Sep 6.

PMID:
21095036
4.

NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their iKIR Negative Counterparts.

Isitman G, Tremblay-McLean A, Lisovsky I, Bruneau J, Lebouché B, Routy JP, Bernard NF.

PLoS One. 2016 Oct 12;11(10):e0164517. doi: 10.1371/journal.pone.0164517. eCollection 2016.

5.

Phenotypical and functional profiles of natural killer cells exhibiting matrix metalloproteinase-mediated CD16 cleavage after anti-HIV antibody-dependent activation.

Tang CC, Isitman G, Bruneau J, Tremblay C, Bernard NF, Kent SJ, Parsons MS.

Clin Exp Immunol. 2015 Aug;181(2):275-85. doi: 10.1111/cei.12593. Epub 2015 Jun 7.

6.

Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals.

Mavilio D, Lombardo G, Benjamin J, Kim D, Follman D, Marcenaro E, O'Shea MA, Kinter A, Kovacs C, Moretta A, Fauci AS.

Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2886-91. Epub 2005 Feb 7.

7.

Activation of natural killer cells by hepatitis C virus particles in vitro.

Farag MM, Weigand K, Encke J, Momburg F.

Clin Exp Immunol. 2011 Sep;165(3):352-62. doi: 10.1111/j.1365-2249.2011.04431.x. Epub 2011 Jun 17.

8.

High CD56++CD16- natural killer (NK) cells among suboptimal immune responders after four years of suppressive antiretroviral therapy in an African adult HIV treatment cohort.

Bayigga L, Nabatanzi R, Sekiziyivu PN, Mayanja-Kizza H, Kamya MR, Kambugu A, Olobo J, Kiragga A, Kirimunda S, Joloba M, Nakanjako D.

BMC Immunol. 2014 Jan 31;15:2. doi: 10.1186/1471-2172-15-2.

9.

Genetically associated CD16(+)56(-) natural killer cell interferon (IFN)-αR expression regulates signaling and is implicated in IFN-α-induced hepatitis C virus decline.

Conry SJ, Meng Q, Hardy G, Yonkers NL, Sugalski JM, Hirsch A, Davitkov P, Compan A, Falck-Ytter Y, Blanton RE, Rodriguez B, Harding CV, Anthony DD.

J Infect Dis. 2012 Apr 1;205(7):1131-41. doi: 10.1093/infdis/jis027. Epub 2012 Feb 20.

10.

Terminal Differentiation of CD56(dim)CD16(+) Natural Killer Cells Is Associated with Increase in Natural Killer Cell Frequencies After Antiretroviral Treatment in HIV-1 Infection.

Ahmad F, Tufa DM, Mishra N, Jacobs R, Schmidt RE.

AIDS Res Hum Retroviruses. 2015 Dec;31(12):1206-12. doi: 10.1089/aid.2015.0115. Epub 2015 Sep 9.

PMID:
26352913
11.

Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-γ production in patients with active disease.

Hervier B, Beziat V, Haroche J, Mathian A, Lebon P, Ghillani-Dalbin P, Musset L, Debré P, Amoura Z, Vieillard V.

Arthritis Rheum. 2011 Jun;63(6):1698-706. doi: 10.1002/art.30313.

12.

Expressions of natural cytotoxicity receptors and NKG2D on decidual natural killer cells in patients having spontaneous abortions.

Zhang Y, Zhao A, Wang X, Shi G, Jin H, Lin Q.

Fertil Steril. 2008 Nov;90(5):1931-7. Epub 2007 Nov 26.

PMID:
18023431
13.

Impaired natural killer cell-induced antibody-dependent cell-mediated cytotoxicity is associated with human immunodeficiency virus-1 disease progression.

Jia M, Li D, He X, Zhao Y, Peng H, Ma P, Hong K, Liang H, Shao Y.

Clin Exp Immunol. 2013 Jan;171(1):107-16. doi: 10.1111/j.1365-2249.2012.04672.x.

14.

Increased number and function of natural killer cells in human immunodeficiency virus 1-positive subjects co-infected with herpes simplex virus 2.

Long BR, Erickson AE, Chapman JM, Barbour JD, Vu BA, Ho EL, Lanier LL, Sauer MM, Carvalho KI, Nixon DF, Kallas EG.

Immunology. 2010 Feb;129(2):186-96. doi: 10.1111/j.1365-2567.2009.03170.x. Epub 2009 Aug 4.

15.

CD56negCD16⁺ NK cells are activated mature NK cells with impaired effector function during HIV-1 infection.

Milush JM, López-Vergès S, York VA, Deeks SG, Martin JN, Hecht FM, Lanier LL, Nixon DF.

Retrovirology. 2013 Dec 18;10:158. doi: 10.1186/1742-4690-10-158.

16.

IL-2-driven regulation of NK cell receptors with regard to the distribution of CD16+ and CD16- subpopulations and in vivo influence after haploidentical NK cell infusion.

Huenecke S, Zimmermann SY, Kloess S, Esser R, Brinkmann A, Tramsen L, Koenig M, Erben S, Seidl C, Tonn T, Eggert A, Schramm A, Bader P, Klingebiel T, Lehrnbecher T, Passweg JR, Soerensen J, Schwabe D, Koehl U.

J Immunother. 2010 Feb-Mar;33(2):200-10. doi: 10.1097/CJI.0b013e3181bb46f7.

PMID:
20145545
17.

Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines.

Sivori S, Parolini S, Marcenaro E, Castriconi R, Pende D, Millo R, Moretta A.

J Neuroimmunol. 2000 Jul 24;107(2):220-5.

PMID:
10854660
18.

Immunophenotypic characterization of normal blood CD56+lo versus CD56+hi NK-cell subsets and its impact on the understanding of their tissue distribution and functional properties.

Lima M, Teixeira MA, Queirós ML, Leite M, Santos AH, Justiça B, Orfão A.

Blood Cells Mol Dis. 2001 Jul-Aug;27(4):731-43.

PMID:
11778657
19.
20.

Distribution of several activating and inhibitory receptors on CD3(-)CD56(+) NK cells in regional lymph nodes of melanoma patients.

Vuletić A, Jurišić V, Jovanić I, Milovanović Z, Nikolić S, Konjević G.

J Surg Res. 2013 Aug;183(2):860-8. doi: 10.1016/j.jss.2013.02.025. Epub 2013 Mar 13.

PMID:
23522458

Supplemental Content

Support Center